How many insider trades does FilingIQ track for MTVA?

FilingIQ tracks 20 Form 4 insider transactions for MTVA (MetaVia Inc.), covering filings from Nov 30, 2024 onwards. 6 of those were filed in the last 90 days.

Are MTVA insiders net buyers or net sellers?

Across the full Form 4 history for MTVA, 2 transactions (10%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MTVA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MTVA in?

MetaVia Inc. (MTVA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.41M.

MTVA insider trading

NasdaqCM Healthcare

MetaVia Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

10% / 0%

Market cap

$6.41M

About MetaVia Inc.

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd.

Company website: www.metaviatx.com

MTVA insider activity at a glance

FilingIQ has scored 20 insider transactions for MTVA since Nov 30, 2024. The most recent filing in our index is dated Jun 8, 2026.

Across the full history, 2 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MTVA insider trades is 70.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MTVA trades on FilingIQ Raw filings on SEC EDGAR

Latest MTVA Form 4 filings

Woodworth Marshall H Chief Financial Officer

P Jun 4, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,223

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 152

Guardant Health, Inc.

KalVista Pharmaceuticals, Inc.

KNSA 129

Kiniksa Pharmaceuticals International, plc

Frequently asked

How many insider trades does FilingIQ track for MTVA?: FilingIQ tracks 20 Form 4 insider transactions for MTVA (MetaVia Inc.), covering filings from Nov 30, 2024 onwards. 6 of those were filed in the last 90 days.
Are MTVA insiders net buyers or net sellers?: Across the full Form 4 history for MTVA, 2 transactions (10%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MTVA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MTVA in?: MetaVia Inc. (MTVA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.41M.

Methodology & sources

Every MTVA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.